Solesence, Inc. Files 8-K for Q1 2026 Financials

Ticker: SLSN · Form: 8-K · Filed: Mar 31, 2026 · CIK: 0000883107

Sentiment: neutral

Topics: financial-results, 8-k, cosmetics

TL;DR

Solesence dropped Q1 2026 results, check the 8-K.

AI Summary

Solesence, Inc. filed an 8-K on March 31, 2026, reporting its results of operations and financial condition for the period ending March 31, 2026. The filing includes a press release and financial statements, with the company's mailing and business address listed as 1319 Marquette Drive, Romeoville, IL 60446.

Why It Matters

This 8-K filing provides investors with crucial updates on Solesence, Inc.'s financial performance and operational results for the first quarter of 2026.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of financial results and does not indicate any unusual or significant risks.

Key Numbers

Key Players & Entities

FAQ

What specific financial results are detailed in the press release?

The filing indicates Item 2.02: Results of Operations and Financial Condition, and includes a press release (EX-99.1), suggesting financial performance details are provided, though the specific numbers are not in this summary.

When was this 8-K filing accepted by the SEC?

The filing was accepted on March 31, 2026, at 08:10:10.

What is Solesence, Inc.'s primary business according to the SIC code?

Solesence, Inc.'s SIC code is 2844, which corresponds to Perfumes, Cosmetics & Other Toilet Preparations.

Where is Solesence, Inc. located?

The company's mailing and business address is 1319 Marquette Drive, Romeoville, IL 60446.

What types of documents are included in this filing?

The filing includes the Form 8-K itself, a press release (EX-99.1), and various XBRL files for interactive data.

Filing Stats: 407 words · 2 min read · ~1 pages · Grade level 10.2 · Accepted 2026-03-31 08:10:10

Key Financial Figures

Filing Documents

02. Results of Operations and Financial Condition

Item 2.02. Results of Operations and Financial Condition. On March 31, 2026, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. 99.1 Press Release dated March 31, 2026 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SOLESENCE, INC. Date: March 31, 2026 By: /s/ Laura Riffner Laura Riffner Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing